Prolonged survival following aggressive treatment for metastatic breast cancer in the spine

Patricia L. Zadnik, Lee Hwang, Derek G. Ju, Mari Groves, Jackson Sui, Alp Yurter, Timothy F Witham, Ali Bydon, Jean Paul Wolinsky, Ziya L. Gokaslan, Daniel Sciubba

Research output: Contribution to journalArticle

Abstract

In 2007, members of our group reported a 21 month median survival for patients undergoing surgery for metastatic breast cancer in the spinal column. Cervical spine metastases were associated with decreased survival, Estrogen receptor positivity was associated with improved survival, and age and visceral metastases did not significantly impact survival. In the current study, we reassess these variables in the context of modern adjuvant therapies, and investigate the impact of the Spinal Instability Neoplastic Score (SINS). We report an observational cohort of 43 patients undergoing surgical resection for metastatic breast cancer of the spine treated at a single academic institution from June 2002 to August 2011. Patient medical records were reviewed in accordance with policies outlined by the University Institutional Review Board. Median overall survival following surgery for metastatic breast cancer in the spine was 26.8 months. 1 year overall survival was 66 %. 5 year-overall survival was 4 %. Age (p = 0.12), preoperative functional status (p = 0.17), location of metastasis (p = 0.34), the presence of visceral metastases (p = 0.68), and spinal instability (p = 0.81) were not significant variables on survival analysis. Postoperative adjuvant therapy with a single modality (radiation or chemotherapy) was associated with a significantly lower median survival compared to dual therapy with chemotherapy and radiation (p = 0.042). Patients that received radiation and chemotherapy after surgery were younger but demonstrated prolonged median survival versus single modality therapy. This data supports the concept that visceral metastases do not impact survival, however cervical spine lesions were not associated with decreased survival.

Original languageEnglish (US)
Pages (from-to)47-55
Number of pages9
JournalClinical and Experimental Metastasis
Volume31
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Spine
Breast Neoplasms
Survival
Neoplasm Metastasis
Therapeutics
Radiation
Drug Therapy
Research Ethics Committees
Survival Analysis
Estrogen Receptors
Medical Records

Keywords

  • Breast cancer
  • Metastasis
  • Outcomes
  • Spine
  • Tumor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prolonged survival following aggressive treatment for metastatic breast cancer in the spine. / Zadnik, Patricia L.; Hwang, Lee; Ju, Derek G.; Groves, Mari; Sui, Jackson; Yurter, Alp; Witham, Timothy F; Bydon, Ali; Wolinsky, Jean Paul; Gokaslan, Ziya L.; Sciubba, Daniel.

In: Clinical and Experimental Metastasis, Vol. 31, No. 1, 01.2014, p. 47-55.

Research output: Contribution to journalArticle

Zadnik, Patricia L. ; Hwang, Lee ; Ju, Derek G. ; Groves, Mari ; Sui, Jackson ; Yurter, Alp ; Witham, Timothy F ; Bydon, Ali ; Wolinsky, Jean Paul ; Gokaslan, Ziya L. ; Sciubba, Daniel. / Prolonged survival following aggressive treatment for metastatic breast cancer in the spine. In: Clinical and Experimental Metastasis. 2014 ; Vol. 31, No. 1. pp. 47-55.
@article{ae37d7d4e3a642109045c03daac337ca,
title = "Prolonged survival following aggressive treatment for metastatic breast cancer in the spine",
abstract = "In 2007, members of our group reported a 21 month median survival for patients undergoing surgery for metastatic breast cancer in the spinal column. Cervical spine metastases were associated with decreased survival, Estrogen receptor positivity was associated with improved survival, and age and visceral metastases did not significantly impact survival. In the current study, we reassess these variables in the context of modern adjuvant therapies, and investigate the impact of the Spinal Instability Neoplastic Score (SINS). We report an observational cohort of 43 patients undergoing surgical resection for metastatic breast cancer of the spine treated at a single academic institution from June 2002 to August 2011. Patient medical records were reviewed in accordance with policies outlined by the University Institutional Review Board. Median overall survival following surgery for metastatic breast cancer in the spine was 26.8 months. 1 year overall survival was 66 {\%}. 5 year-overall survival was 4 {\%}. Age (p = 0.12), preoperative functional status (p = 0.17), location of metastasis (p = 0.34), the presence of visceral metastases (p = 0.68), and spinal instability (p = 0.81) were not significant variables on survival analysis. Postoperative adjuvant therapy with a single modality (radiation or chemotherapy) was associated with a significantly lower median survival compared to dual therapy with chemotherapy and radiation (p = 0.042). Patients that received radiation and chemotherapy after surgery were younger but demonstrated prolonged median survival versus single modality therapy. This data supports the concept that visceral metastases do not impact survival, however cervical spine lesions were not associated with decreased survival.",
keywords = "Breast cancer, Metastasis, Outcomes, Spine, Tumor",
author = "Zadnik, {Patricia L.} and Lee Hwang and Ju, {Derek G.} and Mari Groves and Jackson Sui and Alp Yurter and Witham, {Timothy F} and Ali Bydon and Wolinsky, {Jean Paul} and Gokaslan, {Ziya L.} and Daniel Sciubba",
year = "2014",
month = "1",
doi = "10.1007/s10585-013-9608-3",
language = "English (US)",
volume = "31",
pages = "47--55",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Prolonged survival following aggressive treatment for metastatic breast cancer in the spine

AU - Zadnik, Patricia L.

AU - Hwang, Lee

AU - Ju, Derek G.

AU - Groves, Mari

AU - Sui, Jackson

AU - Yurter, Alp

AU - Witham, Timothy F

AU - Bydon, Ali

AU - Wolinsky, Jean Paul

AU - Gokaslan, Ziya L.

AU - Sciubba, Daniel

PY - 2014/1

Y1 - 2014/1

N2 - In 2007, members of our group reported a 21 month median survival for patients undergoing surgery for metastatic breast cancer in the spinal column. Cervical spine metastases were associated with decreased survival, Estrogen receptor positivity was associated with improved survival, and age and visceral metastases did not significantly impact survival. In the current study, we reassess these variables in the context of modern adjuvant therapies, and investigate the impact of the Spinal Instability Neoplastic Score (SINS). We report an observational cohort of 43 patients undergoing surgical resection for metastatic breast cancer of the spine treated at a single academic institution from June 2002 to August 2011. Patient medical records were reviewed in accordance with policies outlined by the University Institutional Review Board. Median overall survival following surgery for metastatic breast cancer in the spine was 26.8 months. 1 year overall survival was 66 %. 5 year-overall survival was 4 %. Age (p = 0.12), preoperative functional status (p = 0.17), location of metastasis (p = 0.34), the presence of visceral metastases (p = 0.68), and spinal instability (p = 0.81) were not significant variables on survival analysis. Postoperative adjuvant therapy with a single modality (radiation or chemotherapy) was associated with a significantly lower median survival compared to dual therapy with chemotherapy and radiation (p = 0.042). Patients that received radiation and chemotherapy after surgery were younger but demonstrated prolonged median survival versus single modality therapy. This data supports the concept that visceral metastases do not impact survival, however cervical spine lesions were not associated with decreased survival.

AB - In 2007, members of our group reported a 21 month median survival for patients undergoing surgery for metastatic breast cancer in the spinal column. Cervical spine metastases were associated with decreased survival, Estrogen receptor positivity was associated with improved survival, and age and visceral metastases did not significantly impact survival. In the current study, we reassess these variables in the context of modern adjuvant therapies, and investigate the impact of the Spinal Instability Neoplastic Score (SINS). We report an observational cohort of 43 patients undergoing surgical resection for metastatic breast cancer of the spine treated at a single academic institution from June 2002 to August 2011. Patient medical records were reviewed in accordance with policies outlined by the University Institutional Review Board. Median overall survival following surgery for metastatic breast cancer in the spine was 26.8 months. 1 year overall survival was 66 %. 5 year-overall survival was 4 %. Age (p = 0.12), preoperative functional status (p = 0.17), location of metastasis (p = 0.34), the presence of visceral metastases (p = 0.68), and spinal instability (p = 0.81) were not significant variables on survival analysis. Postoperative adjuvant therapy with a single modality (radiation or chemotherapy) was associated with a significantly lower median survival compared to dual therapy with chemotherapy and radiation (p = 0.042). Patients that received radiation and chemotherapy after surgery were younger but demonstrated prolonged median survival versus single modality therapy. This data supports the concept that visceral metastases do not impact survival, however cervical spine lesions were not associated with decreased survival.

KW - Breast cancer

KW - Metastasis

KW - Outcomes

KW - Spine

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84894957980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894957980&partnerID=8YFLogxK

U2 - 10.1007/s10585-013-9608-3

DO - 10.1007/s10585-013-9608-3

M3 - Article

VL - 31

SP - 47

EP - 55

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 1

ER -